Depression in Adolescence and Brain-Derived Neurotrophic Factor.
Boyoung Lee1, Eunjin Shin1, Inwoong Song1
1Center for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon, South Korea.
Frontiers in Molecular Neuroscience
|July 25, 2022
Summary
Adolescent depression is rising, with unclear causes. This review explores environmental, genetic, and brain-derived neurotrophic factor (BDNF) roles in adolescent depression, aiding diagnosis and treatment.
Area of Science:
- Neuroscience
- Psychiatry
- Developmental Psychology
Background:
- Adolescent depression incidence is increasing, driven by environmental and genetic factors.
- Mechanisms underlying adolescent depression remain poorly understood, unlike adult depression.
- Brain-derived neurotrophic factor (BDNF) is crucial in psychiatric disorders, but its role in adolescent depression requires further investigation.
Purpose of the Study:
- To investigate the causes and treatment of adolescent depression.
- To examine the function of brain-derived neurotrophic factor (BDNF) in adolescent depression.
- To address the diagnostic and treatment challenges specific to adolescent depression.
Main Methods:
- Literature review of clinical and preclinical studies.
- Analysis of research on environmental and genetic risk factors.
- Examination of studies focusing on brain-derived neurotrophic factor (BDNF) in adolescent depression.
Main Results:
- Environmental and genetic factors are significant contributors to adolescent depression.
- Differences in symptoms complicate diagnosis and treatment compared to adults.
- BDNF plays a critical role in the pathophysiology of depression, with limited research in adolescents.
Conclusions:
- Further research is needed to elucidate the mechanisms of adolescent depression.
- Understanding BDNF's role is vital for developing targeted adolescent depression treatments.
- Addressing the unique aspects of adolescent depression is crucial for effective intervention.
Related Concept Videos
01:18Depression: Overview
327
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
327
01:05Long-term Depression
31.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.3K
01:27Depressive Disorders: Etiology
162
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
162
01:15Neurogenesis and Regeneration of Nervous Tissue
987
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
987
01:29Drugs Affecting Neurotransmitter Synthesis
1.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
01:30Attention-Deficit/Hyperactivity Disorder
172
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
172